Logos Global Management LP Q1 2020 Filing

Filed May 15, 2020

Portfolio Value

$262.9B

Holdings

40

Report Date

Q1 2020

Filing Type

13F-HR

All Holdings (40 positions)

#StockSharesValue% PortfolioType
1
ABBVABBVIE INC
265,600$20.2B7.70%
2
SRPTSAREPTA THERAPEUTICS INC
187,350$18.3B6.97%
3
MYOKARDIA INC
300,000$14.1B5.35%
4
MRNAMODERNA INC
460,000$13.8B5.24%
5
ASNDASCENDIS PHARMA A S
120,000$13.5B5.14%
6
RETAEURREATA PHARMACEUTICALS INC
82,292$11.9B4.52%
7
BMYBRISTOL-MYERS SQUIBB CO
194,500$10.8B4.12%
8
ZYMEWORKS INC
304,417$10.8B4.11%
9
1K0IGM BIOSCIENCES INC
173,865$9.8B3.71%
10
GBTUSDGLOBAL BLOOD THERAPEUTICS IN
185,933$9.5B3.61%
11
PASGPASSAGE BIO INC
603,338$9.0B3.41%
12
VRTXVERTEX PHARMACEUTICALS INC
33,237$7.9B3.01%
13
BLUBELLUS HEALTH INC NEW
775,377$7.7B2.94%
14
IOVAIOVANCE BIOTHERAPEUTICS INC
247,248$7.4B2.82%
15
FULCFULCRUM THERAPEUTICS INC
532,520$6.4B2.42%
16
ETNBGBP89BIO INC
247,000$6.2B2.37%
17
MRTXEURMIRATI THERAPEUTICS INC
79,699$6.1B2.33%Call
18
MOLECULAR TEMPLATES INC
438,831$5.8B2.22%
19
VSTMVERASTEM INC
2,325,582$5.5B2.10%
20
KRTXKARUNA THERAPEUTICS INC
69,658$5.0B1.91%
21
BMY-RBRISTOL-MYERS SQUIBB CO
1,275,500$4.8B1.84%
22
TXG10X GENOMICS INC
72,831$4.5B1.73%
23
CRSPCRISPR THERAPEUTICS AG
105,512$4.5B1.70%
24
2L9BLUEPRINT MEDICINES CORP
75,000$4.4B1.67%
25
ALNYALNYLAM PHARMACEUTICALS INC
39,644$4.3B1.64%
26
FATEFATE THERAPEUTICS INC
193,144$4.3B1.63%
27
AM6AMICUS THERAPEUTICS INC
446,882$4.1B1.57%
28
TREURTRILLIUM THERAPEUTICS INC
995,600$4.0B1.53%
29
LIFESCI ACQUISITION CORP
400,000$4.0B1.52%
30
ZOGENIX INC
152,144$3.8B1.43%
31
IMMUNOMEDICS INC
276,635$3.7B1.42%
32
BDTXBLACK DIAMOND THERAPEUTICS I
123,465$2.8B1.05%
33
SELBUSDSELECTA BIOSCIENCES INC
1,111,867$2.7B1.02%
34
TGTXTG THERAPEUTICS INC
249,844$2.5B0.93%
35
CYTKCYTOKINETICS INC
193,129$2.3B0.87%
36
SG7SAGE THERAPEUTICS INC
69,591$2.0B0.76%
37
NERVGBPMINERVA NEUROSCIENCES INC
309,745$1.9B0.71%
38
YB4PSAVARA INC
613,999$1.2B0.45%
39
RVMDREVOLUTION MEDICINES INC
53,034$1.2B0.44%
40
RCKTROCKET PHARMACEUTICALS INC
15,809$221.0M0.08%